Season 24 Episode 23
Clinical investigators discuss available data guiding the management of colorectal cancer.
CME information and select publications here.
Published on 4 months ago
Season 24 Episode 22
Clinical investigators discuss available data guiding the management of biliary tract cancers.
CME information and select publications here.
Published on 4 months, 3 weeks ago
Season 24 Episode 21
Clinical investigators discuss available data guiding the management of neuroendocrine tumors.
CME information and select publications here.
Published on 5 months, 1 week ago
Season 24 Episode 20
Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associat…
Published on 5 months, 3 weeks ago
Season 24 Episode 19
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston and Dr Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston summarize the most clinically relevant research…
Published on 6 months ago
Season 24 Episode 18
Dr John Bridgewater from the UCL Cancer Institute in London, United Kingdom, discusses patient cases and summarizes current treatment approaches for cholangiocarcinoma and other biliary tract cancers…
Published on 6 months, 2 weeks ago
Season 24 Episode 17
Dr Arvind Dasari, Dr Van Morris, Dr Jenny Seligmann, Prof Eric Van Cutsem and moderator Dr Christopher Lieu summarize research findings guiding the application of biomarker-driven therapy for patient…
Published on 6 months, 4 weeks ago
Season 24 Episode 16
Dr Anthony El-Khoueiry, Dr Richard Finn, Dr Aiwu Ruth He, Dr Stacey Stein and moderator Dr Stephen “Fred” Divers discuss data from the 2025 ASCO GI meeting and other published studies guiding the car…
Published on 7 months, 1 week ago
Season 24 Episode 15
Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers.
Published on 9 months ago
Season 24 Episode 14
Dr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatobiliary cancers.
Published on 9 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate